Revolutionizing Compounding with PCCA's UniFlow™ Technology

PCCA Launches UniFlow™ to Innovate T3/T4 Compounding

PCCA has made a significant announcement regarding the launch of UniFlow™, a state-of-the-art powder excipient base that promises to revolutionize the landscape of compounding, particularly for potent, low-dose active pharmaceutical ingredients like liothyronine sodium (T3) and levothyroxine sodium (T4). This new formulation is designed with the goal of enhancing flow and content uniformity, improving stability, and cutting preparation times by an impressive 50%.

Transforming Compounding Challenges

According to Daniel Banov, the Vice President of Research and Development at PCCA, "UniFlow is a game-changer for T3 and T4 compounding.” This innovative product has been designed specifically to tackle common formulation hurdles associated with these critical medications. Employing a carefully crafted co-blend technology, UniFlow exhibits low-moisture, high-flowability properties, ensuring better uniformity and stability.

Overcoming Precision Barriers

The intricacies of compounding T3 and T4 require unmatched precision and skill. Traditional methods not only face hurdles like content uniformity failures due to uneven API distribution but also moisture-related degradation of fragile ingredients. This often leads to the necessity for costly retests that slow down work processes. UniFlow is engineered to effectively address these barriers, promoting reliable API distribution while safeguarding sensitive components from environmental moisture.

Proven Success from Beta Testing

Results from beta testers of UniFlow have been overwhelmingly positive, showcasing faster preparation times, simplified handling, and better success rates in potency testing outcomes. Where mortar-and-pestle triturations using microcrystalline cellulose (MCC) would typically consume around 30 minutes, these processes can now be concluded in less than 15 minutes with UniFlow. This remarkable efficiency translates into fewer failed potency tests, leading to reduced waste and overall operational costs for pharmacies.

Commitment to Innovation

PCCA's CEO, Gus Bassani, emphasizes that the name UniFlow is a clever combination of the terms uniformity and flow. He highlights that working with very low concentrations of APIs presents significant challenges in terms of content uniformity, especially with T3 and T4 medications. The development of UniFlow aligns with PCCA’s dedication to practical innovation, turning the insights and feedback from its members into effective, real-world solutions.

Availability for Pharmacy Members

UniFlow (PCCA #30-5264) is currently accessible exclusively to PCCA member pharmacies. Additionally, members utilizing Clinical Services can access a selection of 18 specialized UniFlow formulations created specifically for T3 and T4 triturations, alongside a variety of T3/T4 capsule combinations. Comprehensive technical support reports and further product information are available, ensuring that member pharmacies have all the resources they need.

About PCCA

PCCA takes pride in supporting the evolution of personalized medicine and delivers innovative products that truly enhance patient care. As a leading resource for independent compounding pharmacists and healthcare systems, the organization offers top-quality products, educational resources, and support to more than 3,000 pharmacy members across the globe, including locations in the United States, Canada, Australia, and beyond. Established over 40 years ago by a community of pharmacists, PCCA continues to champion the art and science of pharmacy compounding. Learn more about their initiatives and offers through their official platform.

Frequently Asked Questions

What is UniFlow™ used for in pharmacy compounding?

UniFlow™ is utilized for compounding T3 and T4 medications, designed to enhance the flow and uniformity of potent low-dose active ingredients.

How does UniFlow™ improve compounding efficiency?

UniFlow™ reduces preparation times by 50%, allowing pharmacists to complete processes much faster and with fewer failed potency tests.

Who can access UniFlow™ products?

UniFlow™ is available exclusively to PCCA member pharmacies, with special formulations accessible for those utilizing Clinical Services.

What technology does UniFlow™ utilize?

UniFlow™ features a co-blend technology system that optimizes moisture control and flow characteristics to enhance overall compounding results.

How long has PCCA been in operation?

PCCA has been operational since 1981, supporting pharmacy compounding for over 40 years and advancing personalized medicine.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.